Related Experiment Video
Updated: Dec 7, 2025

Author Spotlight: Assessing the Feasibility of Using Amplitude-Integrated EEG During Neonatal Transport
Published on: June 21, 2024
Adverse events associated with paediatric intrathecal baclofen in Australia: 5 years of data collection
Louise Tyack1, Lisa Copeland1, Lynn McCartney2
1Queensland Paediatric Rehabilitation Service, Queensland Children's Hospital, Brisbane, Queensland, Australia.
Insights
Intrathecal baclofen (ITB) therapy in Australian children has a high rate of adverse events (AEs), with catheter issues and drug-related problems being most common. These findings are crucial for patient counseling regarding ITB risks.
Area of Science:
- Neurology
- Pediatric Medicine
- Pharmacology
Background:
- Intrathecal baclofen (ITB) therapy is used for severe spasticity in children.
- Understanding adverse event (AE) profiles is crucial for patient safety and treatment optimization.
Purpose of the Study:
- To determine the incidence and types of adverse events associated with ITB therapy in Australian pediatric patients.
- To provide data for informed patient and caregiver counseling regarding ITB treatment.
Main Methods:
- Data were extracted from the Australian Paediatric ITB Research Group national database.
- Analysis included the first five years of AE data collection.
- Descriptive statistical analysis was performed on collated data.
Main Results:
- Forty-seven AEs were reported in 23 out of 40 pediatric patients.
- The most frequent AEs included catheter dysfunction (24%), drug overdose/withdrawal/sensitivity (19%), seromas/hematomas (15%), and infections (13%).
- Ten patients (25%) required surgical intervention, and five (12.5%) needed pump removal due to AEs.
Conclusions:
- The rate of adverse events for ITB therapy in this pediatric cohort is substantial.
- Healthcare providers must consider these risks when discussing ITB as a treatment option with patients and families.
Aim:
This study aims to examine the adverse event (AE) rate for intrathecal baclofen (ITB) therapy in an Australian paediatric population and to clarify type and frequency of AEs.
Methods:
AE data were extracted from the Australian Paediatric ITB Research Group national database, to include the first 5 years of data collection. Raw data were collated and analysed descriptively.
Results:
Data were collected for 40 patients. Forty-seven AEs in 23 patients were reported. Ten (25%) patients required surgical intervention related to their AE. Five patients (12.5%) required pump removal. The most frequent ITB-related AEs were catheter dysfunction (24%), drug overdose, withdrawal or sensitivity (19%), seromas and haematomas (15%) and infections (13%).
Conclusions:
The AE rate for ITB therapy is high and needs to be considered when counselling patients regarding ITB as a therapeutic option.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...

